Tang et al. [43] suggested that SOX2 expression was significantly associated with tumor T classification, clinical stage, lymph node metastasis, and recurrence in laryngeal squamous cell carcinoma. Here, SOX2 is linked to laryngeal squamous cell carcinoma.